Dyspnea assessment and adverse events during sputum induction in COPD

BMC Pulmonary Medicine

Volumn 6, Issue , 2006, Pages

  Makris, Demosthenes ^a   Tzanakis, Nikolaos ^a   Moschandreas, Joanna ^a   Siafakas, Nikolaos M ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; OXYGEN; SALBUTAMOL; SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; BRONCHOSPASM; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT TOOL; CLINICAL PROTOCOL; COHORT ANALYSIS; COMORBIDITY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; DYSPNEA; EXERCISE TEST; FEMALE; FORCED EXPIRATORY VOLUME; HEART RATE; HUMAN; KOLMOGOROV SMIRNOV TEST; LONGITUDINAL STUDY; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NAUSEA; OXYGEN SATURATION; PATIENT SAFETY; PROGNOSIS; PROVOCATION TEST; PULSE OXIMETRY; RANK SUM TEST; REPRODUCIBILITY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SPIROMETRY; SPUTUM EXAMINATION; WHEEZING;

AGED; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HEART RATE; HUMANS; MALE; OXYGEN; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY SOUNDS; SALINE SOLUTION, HYPERTONIC; SEVERITY OF ILLNESS INDEX; SODIUM CHLORIDE; SPUTUM; TIME FACTORS; WALKING;

EID: 33746652643     PISSN: 14712466     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-6-17     Document Type: Article

References (35)

1. Pin I, Gibson PG, Kolendowicz R, Girgis-Gabardo A, Denburg JA, Hargreave FE, Dolovich J: Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992, 47:25-9.
2. Pizzichini E, Pizzichini MM, Efthimiadis A, Evans S, Morris MM, Squillace D, Gleich GJ, Dolovich J, Hargreave FE: Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996, 154:308-17.
3. Saetta M, Di Stefano A, Turato G, De Caro R, Bordignon D, Holgate ST, Fabbri LM: Fatal asthma attack during an inhalation challenge with ultrasonically nebulized distilled water. J Allergy Clin Immunol 1995, 95:1285-7.
4. Fahy JV, Boushey HA, Lazarus SC, Mauger EA, Cherniack RM, Chinchilli VM, Craig TJ, Drazen JM, Ford JG, Fish JE, Israel E, Kraft M, Lemanske RF, Martin RJ, McLean D, Peters SP, Sorkness C, Szefler SJ, NHLB1 Asthma Clinical Research Network: Safety and reproducibility of sputum Induction in asthmatic subjects in a multi-center study. Am J Respir Crit Care Med 2001, 163:1470-5.
5. Pizzichini E, Pizzichini MM, Leigh R, Djukanovic R, Sterk PJ: Safety of sputum induction. Eur Respir J 2002:9s-18s.
6. Vlachos-Mayer H, Leigh R, Sharon RF, Hussack P, Hargreave FE: Success and safety of sputum induction in the clinical setting. Eur Respir J 2000, 16:997-1000.
7. Sutherland ER, Pak J, Langmack EL, Silkoff PE, Martin RJ: Safety of sputum induction in moderate-to-severe chronic obstructive pulmonary disease. Respir Med 2002, 96:482-6.
8. Bhowmik A, Seemungal TA, Sapsford RJ, Devalia JL, Wedzicha JA: Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease. Thorax 1998, 53:953-6.
9. Taube C, Holz O, Mucke M, Jorres RA, Magnussen H: Airway response to inhaled hypertonic saline in patients with moderate to severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001, 164:1810-5.
10. Rytila PH, Lindqvsit AE, Laitinen LA: Safety of sputum induction in chronic obstructive pulmonary disease. Eur Respir J 2000, 15:1116-9.
11. Celli BR, MacNee W, ATS/ERS Task Force: Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004, 23:932-46.
12. Siafakas NM, Vermeire P, Pride NB, Paoletti P, Gibson J, Howard P, Yernault JC, Decramer M, Higenbottam T, Postma DS: Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J 1995, 8:1398-420.
13. American Thoracic Society, (ATS): ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002, 166:111-7.
14. Tzanakis N, Chrysofakis G, Tsoumakidou M, Kyriakou D, Tsiligianni J, Bouros D, Siafakas NM: Induced sputum CD8+ T-lymphocyte subpopulations in chronic obstructive pulmonary disease. Respir Med 2004, 98:57-65.
15. Martinez JA, Straccia L, Sobrani E, Silva GA, Vianna EO, Filho JT: Dyspnea scales in the assessment of illiterate patients with chronic obstructive pulmonary disease. Am J Med Sci 2000, 320:240-3.
16. American Thoracic Society, (ATS): Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 1995, 152:1107-36.
17. de a Fuente PT, Romagnoli M, Godard P, Bousquet J, Chanez P: Safety of inducing sputum in patients with asthma of varying severity. Am J Respir Crit Care Med 1998, 157:1127-30.
18. Finnerty JP, Wilmot C, Holgate ST: Inhibition of hypertonic saline-induced bronchoconstriction by terfenadine and flurbiprofen. Evidence for the predominant role of histamine. Am Rev Respir Dis 1989, 140(3):593-7.
19. Wark PA, Simpson JL, Hensley MJ, Gibson PG: Safety of sputum induction with isotonic saline in adults with acute severe asthma. Clin Exp Allergy 2001, 31(11):1745-53.
20. Moloney ED, Griffin S, Burke CM, Poulter LW, O'Sullivan S: Release of inflammatory mediators from eosinophils following a hyperosmolar stimulus. Respir Med 2003, 97(8):928-32.
21. Eggleston PA, Kagey-Sobotka A, Lichtenstein LM: A comparison of the osmotic activation of basophils and human lung mast cells. Am Rev Respir Dis 1987, 135(5):1043-8.
22. Flertcher CM: Bronchitis: an international symposium. Assen: The Netherlands discussion. Charles C. IL: Thomas Springfield; 1961:212-214.
23. Burdon JG, Juniper EF, Killian KJ, Hargreave FE, Campbell EJ: The perception of breathlessness in asthma. Am Rev Respir Dis 1982, 126(5):825-8.
24. Mahler DA, Harver A: A factor analysis of dyspnea ratings, respiratory muscle strength, and lung function in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1992, 145(2 Pt 1):467-70.
25. Eltayara L, Becklake MR, Volta CA, Milic-Emili J: Relationship between chronic dyspnea and expiratory flow limitation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996, 154(6):1726-34.
26. Ferrari K, Goti P, Misuri G, Amendola M, Rosi E, Grazzini M, Iandelli I, Duranti R, Scano G: Chronic exertional dyspnea and respiratory muscle function in patients with chronic obstructive pulmonary disease. Lung 1997, 175(5):311-9.
27. Rutgers SR, ten Hacken NH, Koeter GH, Postma DS: Borg scores before and after challenge with adenosine 5′'-monophosphate and methacholine in subjects with COPD and asthma. Eur Respir J 2000, 16:486-90.
28. Ottanelli R, Rosi E, Ronchi MC, Grazzini M, Lanini B, Stendardi L, Romagnoli I, Bertini S, Duranti R, Scano G: Perception of bronchoconstriction in smokers with airflow limitation. Clin Sci (Lond) 2001, 101(5):515-22.
29. Laveneziana P, Lotti P, Coli C, Birazzi B, Chiti L, Stendardi L, Duranti R, Scano G: Mechanisms of dyspnoea and its language in patients with asthma. Eur Respir J 2006, 27(4):742-7.
30. Tantucci C, Ellaffi M, Duguet A, Zelter M, Similowski T, Derenne JP, Milic-Emili J: Dynamic hyperinflation and flow limitation during methacholine-induced bronchoconstriction in asthma. Eur Respir J 1999, 14:295-301.
31. Kobayashi S, Nishimura M, Yamomoto M, Akiyama Y, Miyamoto K, Kawamaki Y. Relationship between breathlessness and hypoxic and hypercapnic ventilatory response in patients with COPD. Eur Respir J 1996, 9(11):2340-5.
32. Scano G, Stendardi L, Grazzini M: Understanding dyspnoea by its language. Eur Respir J 2005, 25(2):380-5.
33. Mak VHF, Bugler JR, Roberts CM, Spiro SG: Effect of arterial oxygen desaturation on six minute walk distance, perceived effort, and perceived breathlessness in patients with airflow limitation. Thorax 1993, 48:33-38.
34. Renwick DS, Connolly MJ: Factors affecting oxygen saturation during methacholine challenge in a mixed population. Respir Med 1996, 90(8):473-7.
35. Marin JM, Carrizo SJ, Gascon M, Sanchez A, Gallego B, Celli BR: Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001, 163:1395-9.